[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fjEqapb9lhdJOko9SYSLpswd9S8Eht-lunFBQkfPbpCY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":42,"rows":49},"University of Oregon",[4],72,false,19,0,39985,2,68,[14,17,20,23,26,28,30,33],{"name":15,"count":16},"Depression",11,{"name":18,"count":19},"Parenting",10,{"name":21,"count":22},"Parent-Child Relations",8,{"name":24,"count":25},"Health Behavior",5,{"name":27,"count":25},"Anxiety",{"name":29,"count":25},"Substance Use",{"name":31,"count":32},"Child Behavior",4,{"name":34,"count":35},"Mental Health",3,[37],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05206227","Histamine as a Molecular Transducer of Adaptation to Exercise","2025-12-31","alpha-FMH",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,75,93,122,140,158,183],{"intervention":41,"totalTrials":51,"cells":52},1,{"EARLY_PHASE1":53,"PHASE1":65,"PHASE2":67,"PHASE3":69,"PHASE4":71,"NA":73},{"trials":54,"activeCount":51,"soonestReadout":40},[55],{"nctId":38,"briefTitle":39,"status":56,"phases":57,"primaryCompletion":40,"completion":58,"start":59,"enrollment":60,"conditions":61,"interventions":63},"ACTIVE_NOT_RECRUITING",[43],"2027-03-31","2021-07-28",80,[62],"Postexercise Hypotension",[41,64],"Antihistamine",{"trials":66,"activeCount":9},[],{"trials":68,"activeCount":9},[],{"trials":70,"activeCount":9},[],{"trials":72,"activeCount":9},[],{"trials":74,"activeCount":9},[],{"intervention":64,"totalTrials":51,"cells":76},{"EARLY_PHASE1":77,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":91},{"trials":78,"activeCount":51,"soonestReadout":40},[79],{"nctId":38,"briefTitle":39,"status":56,"phases":80,"primaryCompletion":40,"completion":58,"start":59,"enrollment":60,"conditions":81,"interventions":82},[43],[62],[41,64],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[],{"trials":88,"activeCount":9},[],{"trials":90,"activeCount":9},[],{"trials":92,"activeCount":9},[],{"intervention":94,"totalTrials":51,"cells":95},"Erythropoietin",{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":120},{"trials":97,"activeCount":9},[],{"trials":99,"activeCount":9},[],{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[106],{"nctId":107,"briefTitle":108,"status":109,"phases":110,"primaryCompletion":111,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":117},"NCT05734716","Colorado-Oregon Altitude Study","COMPLETED",[47],"2022-08-01","2023-01-01","2021-02-17",121,[116],"Acute Mountain Sickness",[94,118,119],"Iron sucrose","Sterile Sodium Chloride",{"trials":121,"activeCount":9},[],{"intervention":118,"totalTrials":51,"cells":123},{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":132,"NA":138},{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[],{"trials":133,"activeCount":9},[134],{"nctId":107,"briefTitle":108,"status":109,"phases":135,"primaryCompletion":111,"completion":112,"start":113,"enrollment":114,"conditions":136,"interventions":137},[47],[116],[94,118,119],{"trials":139,"activeCount":9},[],{"intervention":119,"totalTrials":51,"cells":141},{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":148,"PHASE4":150,"NA":156},{"trials":143,"activeCount":9},[],{"trials":145,"activeCount":9},[],{"trials":147,"activeCount":9},[],{"trials":149,"activeCount":9},[],{"trials":151,"activeCount":9},[152],{"nctId":107,"briefTitle":108,"status":109,"phases":153,"primaryCompletion":111,"completion":112,"start":113,"enrollment":114,"conditions":154,"interventions":155},[47],[116],[94,118,119],{"trials":157,"activeCount":9},[],{"intervention":159,"totalTrials":51,"cells":160},"Essential Amino Acids",{"EARLY_PHASE1":161,"PHASE1":163,"PHASE2":165,"PHASE3":177,"PHASE4":179,"NA":181},{"trials":162,"activeCount":9},[],{"trials":164,"activeCount":9},[],{"trials":166,"activeCount":9},[167],{"nctId":168,"briefTitle":169,"status":109,"phases":170,"primaryCompletion":171,"completion":171,"start":172,"enrollment":60,"conditions":173,"interventions":176},"NCT02145949","Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults",[45],"2020-02","2014-12",[174,175],"Muscle Atrophy","Quality of Life",[159],{"trials":178,"activeCount":9},[],{"trials":180,"activeCount":9},[],{"trials":182,"activeCount":9},[],{"intervention":184,"totalTrials":51,"cells":185},"Sildenafil",{"EARLY_PHASE1":186,"PHASE1":200,"PHASE2":202,"PHASE3":204,"PHASE4":206,"NA":208},{"trials":187,"activeCount":9},[188],{"nctId":189,"briefTitle":190,"status":109,"phases":191,"primaryCompletion":192,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":199},"NCT03945643","Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?",[43],"2023-01-31","2023-07-31","2019-07-01",82,[197,198],"Patent Foramen Ovale","Intrapulmonary Arteriovenous Anastamosis",[184],{"trials":201,"activeCount":9},[],{"trials":203,"activeCount":9},[],{"trials":205,"activeCount":9},[],{"trials":207,"activeCount":9},[],{"trials":209,"activeCount":9},[]]